Abstract:Abstract Background Krüppel-like factor 4 (KLF4) is a member of the zinc finger transcription factor family and plays an important role in cell proliferation, differentiation, apoptosis, embryonic development, organ formation, and tumor invasion. There is little research on the clinicopathological characteristics and KLF4 expression in non-small cell lung cancer (NSCLC). Methods We conducted a retrospective study to further explore the correlation between KLF4 expression and clinicopathological features of NSCLC by immunohistochemical staining. Results This study included 81 males (52.3%), 74 females (47.7%), and 101 (65.2%) ages <65, 54 (34.8%) ages ≥65 years. A total number of 127 cases (81.9%) were adenocarcinoma, 26 cases (16.8%) were squamous cell carcinoma, and 2 cases (1.3%) were large cell carcinoma. There were 140 patients (89.7%) in T1-T2 phase and 15 patients in T3-T4 phase; 130 patients (83.9%) in N0 phase and 25 patients (16.1%) in N1-N3 phase. There were no distant metastases in 154 patients (99.4%), and only 1 patient (0.6%) was in M1 phase. In terms of clinical stage, 142 patients (91.6%) in stage I-II and 13 patients (8.4%) in stage III-IV. The number of patients with smoking history was 40 (25.8%). KLF4 expression in NSCLC tissues was significantly decreased compared with normal lung tissues (P<0.001); KLF4 expression in adenocarcinoma was lower than that in normal lung tissues (P<0.001), while there was no significant difference in quamous cell carcinoma (P=0.314). Higher KLF4 expression was significantly associated with clinicopathological features of NSCLC such as squamous cell carcinoma (P<0.001), later T stage (T3-T4 stage) (P=0.013), lymph node metastasis (P=0.011), later clinical stage (III-IV stage) (P=0.001). KLF4 expression was not associated with age (P=0.082); there was no significant difference in KLF4 expression between male and female patients with adenocarcinoma (P=0.709). It was also found that KLF4 was positively correlated with Ki-67 expression in patients with adenocarcinoma (r=0.272, P=0.002). Conclusions Aboval all, the tumor suppressor gene KLF4 might become a potential biomarker and a new therapeutic target for lung cancer patients.

Overexpression of Krüppel-Like Factor 4 Suppresses Migration and Invasion of Non-Small Cell Lung Cancer Through C-Jun-nh2-terminal Kinase/Epithelial-Mesenchymal Transition Signaling Pathway

Putative Tumor-Suppressive Function of Krüppel-Like Factor 4 in Primary Lung Carcinoma

KLF4 Downregulates Htert Expression and Telomerase Activity to Inhibit Lung Carcinoma Growth.

KLF4 overcomes tamoxifen resistance by suppressing MAPK signaling pathway and predicts good prognosis in breast cancer

Krüppel-Like Factor 4 Inhibits Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis by Down-Regulating Caveolin-1 Expression

Deficiency of Kruppel-like Factor KLF4 in Myeloid-Derived Suppressor Cells Inhibits Tumor Pulmonary Metastasis in Mice Accompanied by Decreased Fibrocytes

KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression.

Suppression of Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells by Krüppel-like Factor 4.

Transcription Factor&nbsp;KLF4: A Potential Biomarker of Non-small Cell Lung Cancertranscription Factor&nbsp;KLF4: A Potential Biomarker of Non-small Cell Lung Cancer

Epigenetic Alterations of Krüppel-like Factor 4 and Its Tumor Suppressor Function in Renal Cell Carcinoma.

Knockdown Of Toll-Like Receptor 4 Inhibits Human Nsclc Cancer Cell Growth And Inflammatory Cytokine Secretion In Vitro And In Vivo

KLF4α Up-regulation Promotes Cell Cycle Progression and Reduces Survival Time of Patients with Pancreatic Cancer

Krüpple-like-factor 4 Attenuates Lung Fibrosis Via Inhibiting Epithelial-mesenchymal Transition

Krüppel-Like Factor 6 Downregulation Is Connected with a Poor Prognosis and Tumor Growth in Non-Small-Cell Lung Cancer

NEK4 Kinase Regulates EMT to Promote Lung Cancer Metastasis

IKZF4 acts as a novel tumor suppressor in non–small cell lung cancer by suppressing Notch signaling pathway

Epithelial-mesenchymal Reprogramming by KLF4-regulated Rictor Expression Contributes to Metastasis of Non-Small Cell Lung Cancer Cells.

An RFC4/Notch1 signaling feedback loop promotes NSCLC metastasis and stemness

ZIP4 Promotes Non-Small Cell Lung Cancer Metastasis by Activating Snail-N-cadherin Signaling Axis

CircKIF4A promotes non-small cell lung cancer proliferation and metastasis through MiR-1238/CLDN14 axis

The feedback loop between miR-124 and TGF-β pathway plays a significant role on non-small cell lung cancer metastasis.